Comparison of 34βE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies

Howard Wu, Odeta Lapkus, Mykim Corbin

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

P63, a homologue of p53, was recently identified as a useful basal cell-specific marker. We compared the sensitivity and specificity of p63 with the widely used high-molecular-weight keratin 34βE12 for the diagnosis of prostate carcinoma in needle biopsies. We selected 100 consecutive prostate carcinoma diagnosed by needle biopsies with an adequate number of cancerous glands on the slide. We chose 1 representative hematoxylin and eosin-stained slide from each case and gave it a Gleason score. The same paraffin block was retrieved for 34βE12 and p63 stains. We compared staining patterns of 34βE12 and p63 on both malignant glands and benign glands and recorded basal cell density (percentage of basal cells with positive staining in the benign glands). The cases were divided into 3 groups according to the Gleason score: 5 to 6 (31 cases), 7 (46 cases), and 8 to 10 (23 cases). In 20 cases, focal and patchy staining in a basal cell distribution in malignant glands (range, 1%-20%; mean, 6.6%) was demonstrated (19 by both stains and 1 by 34βE12 only). In 1 case with a Gleason score of 9, the cancer cells, not the basal cells, were stained focally by p63 but not by 34βE 12. Higher-grade tumors demonstrated higher numbers of malignant glands with basal cell staining (1.65% for Gleason 7, 1.26% for Gleason 8-10, compared with 0.42% for Gleason 5-6). The overall specificity of the absence of basal cell staining in the malignant glands for 34βE12 and p63 was 98.63% and 98.60%, respectively. In 17 cases, both stains revealed total absence of basal cell staining in some benign glands (range, 1%-10%; mean, 3.5%). The overall sensitivity in identifying basal cells in benign glands was 99.48% and 99.44% for 34β12 and p63, respectively. Basal cell density was higher for 34βE12 in comparison with p63 (92% vs. 87%). For diagnosing prostate carcinoma in the needle biopsies, p63 is as specific and sensitive ospitalHospital as as 34βE12 and therefore can be used as a complementary basal cell-specific stain for 34βE12 in difficult cases.

Original languageEnglish (US)
Pages (from-to)285-289
Number of pages5
JournalApplied Immunohistochemistry and Molecular Morphology
Volume12
Issue number4
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Needle Biopsy
Prostate
Carcinoma
Staining and Labeling
Neoplasm Grading
Coloring Agents
Basal Cell Neoplasms
Cell Count
Hematoxylin
Eosine Yellowish-(YS)
Keratins
Paraffin
Molecular Weight
Sensitivity and Specificity

Keywords

  • 34βE12
  • Basal cell
  • High molecular weight cytokeratin
  • p63
  • Prostate cancer

ASJC Scopus subject areas

  • Anatomy
  • Medical Laboratory Technology

Cite this

Comparison of 34βE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies. / Wu, Howard; Lapkus, Odeta; Corbin, Mykim.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 12, No. 4, 12.2004, p. 285-289.

Research output: Contribution to journalArticle

@article{db12abc13f80412286190e1fb37ad8cb,
title = "Comparison of 34βE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies",
abstract = "P63, a homologue of p53, was recently identified as a useful basal cell-specific marker. We compared the sensitivity and specificity of p63 with the widely used high-molecular-weight keratin 34βE12 for the diagnosis of prostate carcinoma in needle biopsies. We selected 100 consecutive prostate carcinoma diagnosed by needle biopsies with an adequate number of cancerous glands on the slide. We chose 1 representative hematoxylin and eosin-stained slide from each case and gave it a Gleason score. The same paraffin block was retrieved for 34βE12 and p63 stains. We compared staining patterns of 34βE12 and p63 on both malignant glands and benign glands and recorded basal cell density (percentage of basal cells with positive staining in the benign glands). The cases were divided into 3 groups according to the Gleason score: 5 to 6 (31 cases), 7 (46 cases), and 8 to 10 (23 cases). In 20 cases, focal and patchy staining in a basal cell distribution in malignant glands (range, 1{\%}-20{\%}; mean, 6.6{\%}) was demonstrated (19 by both stains and 1 by 34βE12 only). In 1 case with a Gleason score of 9, the cancer cells, not the basal cells, were stained focally by p63 but not by 34βE 12. Higher-grade tumors demonstrated higher numbers of malignant glands with basal cell staining (1.65{\%} for Gleason 7, 1.26{\%} for Gleason 8-10, compared with 0.42{\%} for Gleason 5-6). The overall specificity of the absence of basal cell staining in the malignant glands for 34βE12 and p63 was 98.63{\%} and 98.60{\%}, respectively. In 17 cases, both stains revealed total absence of basal cell staining in some benign glands (range, 1{\%}-10{\%}; mean, 3.5{\%}). The overall sensitivity in identifying basal cells in benign glands was 99.48{\%} and 99.44{\%} for 34β12 and p63, respectively. Basal cell density was higher for 34βE12 in comparison with p63 (92{\%} vs. 87{\%}). For diagnosing prostate carcinoma in the needle biopsies, p63 is as specific and sensitive ospitalHospital as as 34βE12 and therefore can be used as a complementary basal cell-specific stain for 34βE12 in difficult cases.",
keywords = "34βE12, Basal cell, High molecular weight cytokeratin, p63, Prostate cancer",
author = "Howard Wu and Odeta Lapkus and Mykim Corbin",
year = "2004",
month = "12",
language = "English (US)",
volume = "12",
pages = "285--289",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Comparison of 34βE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies

AU - Wu, Howard

AU - Lapkus, Odeta

AU - Corbin, Mykim

PY - 2004/12

Y1 - 2004/12

N2 - P63, a homologue of p53, was recently identified as a useful basal cell-specific marker. We compared the sensitivity and specificity of p63 with the widely used high-molecular-weight keratin 34βE12 for the diagnosis of prostate carcinoma in needle biopsies. We selected 100 consecutive prostate carcinoma diagnosed by needle biopsies with an adequate number of cancerous glands on the slide. We chose 1 representative hematoxylin and eosin-stained slide from each case and gave it a Gleason score. The same paraffin block was retrieved for 34βE12 and p63 stains. We compared staining patterns of 34βE12 and p63 on both malignant glands and benign glands and recorded basal cell density (percentage of basal cells with positive staining in the benign glands). The cases were divided into 3 groups according to the Gleason score: 5 to 6 (31 cases), 7 (46 cases), and 8 to 10 (23 cases). In 20 cases, focal and patchy staining in a basal cell distribution in malignant glands (range, 1%-20%; mean, 6.6%) was demonstrated (19 by both stains and 1 by 34βE12 only). In 1 case with a Gleason score of 9, the cancer cells, not the basal cells, were stained focally by p63 but not by 34βE 12. Higher-grade tumors demonstrated higher numbers of malignant glands with basal cell staining (1.65% for Gleason 7, 1.26% for Gleason 8-10, compared with 0.42% for Gleason 5-6). The overall specificity of the absence of basal cell staining in the malignant glands for 34βE12 and p63 was 98.63% and 98.60%, respectively. In 17 cases, both stains revealed total absence of basal cell staining in some benign glands (range, 1%-10%; mean, 3.5%). The overall sensitivity in identifying basal cells in benign glands was 99.48% and 99.44% for 34β12 and p63, respectively. Basal cell density was higher for 34βE12 in comparison with p63 (92% vs. 87%). For diagnosing prostate carcinoma in the needle biopsies, p63 is as specific and sensitive ospitalHospital as as 34βE12 and therefore can be used as a complementary basal cell-specific stain for 34βE12 in difficult cases.

AB - P63, a homologue of p53, was recently identified as a useful basal cell-specific marker. We compared the sensitivity and specificity of p63 with the widely used high-molecular-weight keratin 34βE12 for the diagnosis of prostate carcinoma in needle biopsies. We selected 100 consecutive prostate carcinoma diagnosed by needle biopsies with an adequate number of cancerous glands on the slide. We chose 1 representative hematoxylin and eosin-stained slide from each case and gave it a Gleason score. The same paraffin block was retrieved for 34βE12 and p63 stains. We compared staining patterns of 34βE12 and p63 on both malignant glands and benign glands and recorded basal cell density (percentage of basal cells with positive staining in the benign glands). The cases were divided into 3 groups according to the Gleason score: 5 to 6 (31 cases), 7 (46 cases), and 8 to 10 (23 cases). In 20 cases, focal and patchy staining in a basal cell distribution in malignant glands (range, 1%-20%; mean, 6.6%) was demonstrated (19 by both stains and 1 by 34βE12 only). In 1 case with a Gleason score of 9, the cancer cells, not the basal cells, were stained focally by p63 but not by 34βE 12. Higher-grade tumors demonstrated higher numbers of malignant glands with basal cell staining (1.65% for Gleason 7, 1.26% for Gleason 8-10, compared with 0.42% for Gleason 5-6). The overall specificity of the absence of basal cell staining in the malignant glands for 34βE12 and p63 was 98.63% and 98.60%, respectively. In 17 cases, both stains revealed total absence of basal cell staining in some benign glands (range, 1%-10%; mean, 3.5%). The overall sensitivity in identifying basal cells in benign glands was 99.48% and 99.44% for 34β12 and p63, respectively. Basal cell density was higher for 34βE12 in comparison with p63 (92% vs. 87%). For diagnosing prostate carcinoma in the needle biopsies, p63 is as specific and sensitive ospitalHospital as as 34βE12 and therefore can be used as a complementary basal cell-specific stain for 34βE12 in difficult cases.

KW - 34βE12

KW - Basal cell

KW - High molecular weight cytokeratin

KW - p63

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=10044292938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044292938&partnerID=8YFLogxK

M3 - Article

C2 - 15536326

AN - SCOPUS:10044292938

VL - 12

SP - 285

EP - 289

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 4

ER -